Brief: Jacobio Completes First Patient Dosage Of Cd73 Mab Jab-Bx102 In China
02/09/2022 12:25
Sept 2 (Reuters) - Jacobio Pharmaceuticals Group Co Ltd
1167.HK :
* JACOBIO COMPLETES FIRST PATIENT DOSAGE OF CD73 MAB
JAB-BX102 IN
CHINA
Source text for Eikon: ID:nPnbmyjKza
Further company coverage: 1167.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Jacobio Pharmaceuticals
See all newsBrief: Jacobio Pharmaceuticals Appoints Xiaojie Wang As Vice Chairperson
China's Jacobio Pharmaceuticals H1 revenue jumps on licensing boost
Brief: Jacobio Pharmaceuticals Group Posts H1 Net Income Attributable RMB 600.6 Million
Brief: Jacobio Pharmaceuticals Expects HY Net Profit Of Not Less Than RMB600 Million
HK-listed Jacobio Pharmaceuticals climbs on share buyback plan